Cardiogenic Shock Clinical Trials Cardiogenic Shock RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock
Conditions:   Cardiogenic Shock;   Microbial Colonization;   Out-Of-Hospital Cardiac Arrest;   Acute Heart Failure;   Acute Myocardial Infarction Intervention:   Other: Observational study Sponsor:   University Hospital, Essen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials

A Randomized, Placebo-controlled Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Condition:   Cardiogenic Shock Interventions:   Drug: Istaroxime;   Drug: Placebo Sponsors:   Windtree Therapeutics;   Momentum Research, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Condition:   Cardiogenic Shock Interventions:   Drug: Istaroxime;   Drug: Placebo Sponsor:   Windtree Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials

A Randomized, Placebo-controlled Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Condition:   Cardiogenic Shock Interventions:   Drug: Istaroxime;   Drug: Placebo Sponsors:   Windtree Therapeutics;   Momentum Research, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials